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Abstract 
We report a case of a metastatic signet ring cell carcinoma (SRCC) of gastrointestinal tract. 
The case is very rare because gastrointestinal tract SRCC was metastatic to bilateral breasts 
and ovaries (Krukenberg tumor) in the same young woman almost synchronously under 
breastfeeding condition. Though the primary site was not detected, IHC results fully verified 
that the tumor originated from gastrointestinal tract. The severe situation of the patient was 
believed to be connected to her high estrogen hormone. 
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Introduction 
Metastasis of gastrointestinal carcinomas to bi-
lateral ovaries is usually seen, and the metastatic tu-
mors are called Krukenberg tumors. A few cases have 
been reported of breast metastatic tumors from both 
gastrointestinal  tract  and  gastrointestinal  tumors 
metastatic  from  breast  [1-3].  However,  literature  of 
metastatic  gastrointestinal  tract  carcinomas  to  bilat-
eral  breasts  and  ovaries  at  the  same  time  under 
breastfeeding  condition  cannot  be  found.  Here  we 
describe  an  unusual  case  of  gastrointestinal  signet 
ring cell carcinoma (SRCC) metastatic to the bilateral 
breasts and ovaries during breastfeeding period.  
In  July  2009,  a  27-year-old  woman  with  two 
children  was  breastfeeding  her  second  4-month-old 
baby. At first she felt right breast a little tough. After 
about one month, the left one also became hard. At the 
same time, two breasts had no painfulness and other 
uncomfortable feelings except of hardness. And then, 
her  baby  refused  to  suck  her  breasts.  In  September 
2009,  she  saw  a  doctor  in  her  countryside  hospital. 
The doctor said that she suffered from mastitis and 
gave her some medicine. But the conditions became 
severed. Finally, her bilateral breasts seemed as hard 
as stones (Fig. 1). However, since the doctor said that 
it was just mastitis, she was not worry about it.  
In the beginning of 2010, she was presented with 
weakness, abdominal distension, slight pain and 5kg 
weight loss, but there were not bloodiness, diarrhea 
and changes in stool-shape. She went to the hospital 
again.  After  physical  examination  and  abdominal 
ultrasound, doctor found a lump in bilateral ovaries, 
and considerable ascitic fluid. She was transferred to 
our  hospital  and  re-examined,  and  the  same  signs 
were  found  under  ultrasound  (Fig  2).  Because  her 
bilateral  breasts  were  still  very  hard,  coarse  needle 
biopsy was operated on  March 3, 2010.  The Hema-
toxylin-Eosin (H&E) staining revealed that a quantity 
of signet ring-like cells were diffused among fibrous 
tissues. Several residual breast little ducts and glands 
were  scattered  in  tumors.  Special  staining  verified 
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Alcian Blue (AB) staining was positive. The most of 
breast  SRCC  occur  on  the  postmenopausal  women. 
Was the present SRCC of breast occurred in the young 
lady?  Immunohistochemistry  (IHC)  was  operated. 
ER, PR, E-Cadherin, and CK7 were positive in breast 
gland epithelium, and negative in tumor cells. CK20, 
CA199, CDX2 and Villin were positive in tumor cells 
(Fig  3),  CerbB2  and  CA125  negative.  These  results 
demonstrated that the tumor was a metastatic carci-
noma  from  gastrointestinal  tract,  and  not  a  breast 
primary one. How about bilateral ovary tumors? Af-
ter one course of chemotherapy and on April 13, op-
erations of bilateral ovaries were carried out. During 
operation,  intraoperative frozen-section examination 
appeared ring cells among fibrous tissues of ovaries 
as observed in breast sections. Moreover, it was found 
that there were nodules on uterine and oviduct sero-
sas,  omentum,  mesentery,  and  rectal  surface  with 
hemorrhagic ascites. Interestingly, H&E and IHC of 
lesions of bilateral ovaries and those nodules in ab-
domen  were  all  consistent  with  those  of  the  breast 
tumors  (Fig  4).  On  June  16,  2010,  the  patient  took 
fourth  course  of  chemotherapy.  During  this  course, 
she appeared digestive obstruction symptom-several 
days’ diarrhea and then stopping exhaust. The clinic 
doctors doubted her intestine was blocked by a tu-
mor. Because of her poor physique, she  didn’t take 
endoscopy  detection.  Finally,  the  patient  died  with 
cachexia on Sep 12, 2010. 
 
 
Figure 1 Tough lumps of bilateral breasts with inverted nipples. (These photos were taken after the third course of 
chemotherapy.) 
 
Figure 2 Abdominal ultrasound detection appeared that lumps in bilateral ovaries with rich blood supply (). Fluid son-
olucent areas were seen besides ovaries (→).  Journal of Cancer 2011, 2 
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Figure 3 HE staining and ISH of metastatic SRCC in breast. A-B. The hematoxylin-eosin(H&E) staining revealed that a 
quantities of signet ring-like cells were diffused among fibrous tissues and several residual breast little ducts and glands were 
scattered in tumors (→) (A: H&E ×200, B: H&E ×400). C-D. AB and PAS staining appealed blue and red positive signal in 
cytoplasm of signet ring-like cells (×400). E-H. CK20, Villin, CA199 and CDX2 positive expression in ring-like cells (E: 
Envision×200, F-H: Envision×400). I-L. CK7, ER, E-cadherin, CK5/6 negative express in tumor cells and positive in residual 
breast little ducts and glands (Envision×200). 
 
 
It was very regret that the gastrointestinal orig-
inal lesions could not be  obtained. Even  so, a clear 
conclusion  could  be  drawn  from  the  clinical  and 
pathological data that tumors of bilateral breasts and 
ovaries were metastatic from gastrointestinal tract. In 
other  words,  Primary  tumor  was  originated  from 
gastrointestinal tract. An analysis of 112 Krukenberg 
tumors in ovaries in 2006 found primary carcinomas 
were detected synchronously with, or subsequent to, 
detection  of  the  only  two  thirds  Krukenberg  tumor 
[4].  
Discussion 
In present case, many tumors  with the similar 
H&E images were found in bilateral breasts, ovaries 
and abdomen. Where is the primary site? IHC verified 
the  tumor  originated  from  gastrointestinal  tract.  A 
variety of immunologic markers have been applied to 
distinguish  SRCCs  from  the  breast,  stomach,  and 
gastrointestinal tract. Firstly, although ER is an effec-
tive mark in breast carcinoma, one study showed that 
approximately 20% of breast SRCCs can be negative 
for ER [5]. While in the other study, up to 30% of gas-
trointestinal  adenocarcinomas  were  ER  positive  [6]. 
Therefore, ER cannot be a single mark to distinguish 
these  tumors.  Secondly,  adenocarcinomas  of  the 
breast, ovary and gastrointestinal tract show different 
CK7  and  CK20  expression  patterns.  In  breast  and 
ovary adenocarcinomas, CK7 is positive and CK20 is 
negative.  In  contrast,  CK20  is  positive  and  CK7  is 
negative in gastrointestinal ones [5,6]. In a word, the 
combination of CK7, CK20 and ER could play some 
role in differentiating SRCC origination. 
In recent years, some new antibodies were used 
as specific markers for distinction. For example, Villin 
is mainly produced by epithelial cells that develop a 
brush border. Cells producing Villin are reported to 
be found in the epithelial cells of the intestinal mucosa 
and gall bladder. So, Villin could be a useful marker 
for  gastrointestinal  carcinoma.  Another  antibody,  Journal of Cancer 2011, 2 
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CDX2, is considered to be a special marker for gas-
trointestinal  carcinomas.  It  is  a  caudal-type  homeo-
box, intestine-specific transcription factor that is ex-
pressed early in intestinal development and may be 
involved  in  the  regulation  of  proliferation  and  dif-
ferentiation of intestinal epithelial cells. One study [7] 
has demonstrated CDX2 expressed in all cases of col-
orectal  adenocarcinoma  and  almost  50%  of  gastric 
adenocarcinomas, meanwhile, only rare cases of ad-
enocarcinomas of the genitourinary and gynecologic 
tracts, breast, lung, and head and neck show signifi-
cant  levels  of  CDX2.  Another  study  [8]  found  that 
CDX2 negative in breast SRCC, 89% and 90% in gas-
trointestinal  tract  and  gastric  SRCC  respectively.  In 
comparison with Villin which is sensitive and special 
for gastrointestinal adenocarcinoma, CDX2 is an eas-
ier marker for evaluation because it expresses in nu-
clei while Villin is restricted to the apical surface and 
there may be more false-positives.  
IHC  of  the  present  case  showed  that  ER,  PR, 
CerbB2,  E-Cadherin  and  CK7  were  negative,  CK20, 
CDX2  and  Villin  were  positive.  According  to  the 
above  theories  and  studies,  its  gastrointestinal  tract 
origination is assured.  
 
 
Figure 4 Metastatic SRCC on ovaries and oviducts. A. H&E staining showed that signet ring-like cells were diffused among 
ovarian stromal tissues (H&E×200). B. Tumor cells invade serosa of oviduct (→) (H&E×200). C-E. CK20, Villin, CDX2 
positive expression in SRCC (Envision×400).  Journal of Cancer 2011, 2 
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Why the tumor in this case advanced so rapidly 
and severely in the only half-year? It may be closely 
related  to  the  breastfeeding  condition.  As  known, 
during  pregnancy  and  breastfeeding  periods,  estro-
gen hormone is always presented in high levels.  
Some  studies  indicate  that  pregnancy  and 
breastfeeding do not influence tumor advance com-
pared with other people with similar stage and age 
[9]. A poorer prognosis of the tumors in pregnancy 
and breastfeeding women diagnosed at a later stage 
attributed to pregnancy. For example, the symptoms 
of  colorectal  cancer  include  nausea,  vomiting,  ab-
dominal  pain,  and  rectal  bleeding.  Physicians  and 
pregnant  women  often  assumed  these  are  normal 
pregnant reactions and therefore miss early diagnosis 
[10]. Some studies believes that during pregnancy and 
breastfeeding periods, the increased vascularity of the 
breast,  high  circulating  levels  of  hormones  and  im-
mune suppressed state of pregnancy accelerate cancer 
development  [11].  Similar  to  malignant  melanoma, 
pregnant women may present with more invasive or 
advanced disease due to hormonal or growth factor 
effects  [12].  Moreover,  one  study  of  a  clinicopatho-
logic analysis of 112 cases of Krukenberg tumors of 
the  ovary  found  that  in  the  patients  with  a  recent 
pregnancy,  the  abdominal  mass  developed  rapidly 
after  delivery.  In  addition,  estrogen  receptors  were 
present  in  all  experimented  cases.  It  suggested  that 
estrogen influences tumor development.  
In the present case, we do not know when the 
gastrointestinal  tract  tumor  grew  and  migrated  to 
breasts and ovaries. However, we believe that preg-
nancy and breastfeeding accelerate the tumor devel-
opment.  According  to  our  and  others’  experiences, 
SRCC  type  Krukenberg  tumors  are  often  seen  in 
young women [13, 14] and breast metastasis are rare. 
Until now, case like ours has not been reported. We 
speculate the tumor could not aggravate so rapidly if 
there is no pregnancy and breastfeeding.  
In  conclusion,  tumors  in  pregnant  and  breast-
feeding woman should be thought of and not be dis-
guised by pregnancy symptoms. 
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